246
drying the beads. Under conditions of low relative humidity,
the beads air-dry rapidly. Do not overdry.- The enriched ion sphere particles can be stored at 2–8 °C for
up to 3 days. - When performing two sequencing runs from the same initial-
ization, the second run must start within 24 h after start of
initialization.
References
- Mardis ER (2013) Next-generation sequencing
platforms. Annu Rev Anal Chem 6:287–303 - Pillai S, Gopalan V, Lo CY et al (2016) Silent
genetic alterations identified by targeted next-
generation sequencing in pheochromocy-
toma/paraganglioma: a clinicopathological
correlations. Exp Mol Pathol 102:41–46 - Zheng H, Wang Y, Tang C et al (2016) TP53,
PIK3CA, FBXW7 and KRAS mutations in
esophageal cancer identified by targeted sequenc-
ing. Cancer Genomics Proteomics 13:231–238 - Weaver JM, Ross-Innes CS, Fitzgerald RC
(2014) The ‘-omics’ revolution and esopha-
geal adenocarcinoma. Nat Rev Gastroenterol
Hepatol 11:19–27 - van El CG, Cornel MC, Borry P et al (2013)
Whole-genome sequencing in health care:
recommendations of the European Society of
Human Genetics. Eur J Hum Genet 21:1–5 - Ding L, Wendl MC, Koboldt DC et al (2010)
Analysis of next-generation genomic data in
cancer: accomplishments and challenges. Hum
Mol Genet 19:188–196 - Ross-Innes CS, Becq J, Warren A et al (2015)
Whole-genome sequencing provides new
insights into the clonal architecture of Barrett’s
esophagus and esophageal adenocarcinoma.
Nat Genet 47:1038–1046 - Dulak AM, Stojanov P, Peng S et al (2013)
Exome and whole-genome sequencing of
esophageal adenocarcinoma identifies recur-
rent driver events and mutational complexity.
Nat Genet 45:478–486 - Streppel MM, Lata S, DelaBastide M et al
(2014) Next-generation sequencing of endo-
scopic biopsies identifies ARID1A as a tumor-
suppressor gene in Barrett’s esophagus.
Oncogene 33:347–357 - Bainbridge MN, Wang M, Burgess DL et al
(2010) Whole exome capture in solution with
3 Gbp of data. Genome Biol 11:R62
11. Meyerson M, Gabriel S, Getz G (2010)
Advances in understanding cancer genomes
through second-generation sequencing. Nat
Rev Genet 11:685–696
12. Rabbani B, Tekin M, Mahdieh N (2014) The
promise of whole-exome sequencing in medi-
cal genetics. J Hum Genet 59:5–15
13. Agrawal N, Jiao Y, Bettegowda C, Hutfless
SM et al (2012) Comparative genomic
analysis of esophageal adenocarcinoma and
squamous cell carcinoma. Cancer Discov
2:899–905
14. Wang X, Li X, Cheng Y et al (2015) Copy
number alterations detected by whole-exome
and whole-genome sequencing of esophageal
adenocarcinoma. Hum Genomics 9:22
15. Findlay JM, Castro-Giner F, Makino S et al
(2016) Differential clonal evolution in esopha-
geal cancers in response to neo-adjuvant che-
motherapy. Nat Commun 7:11111
16. Parla JS, Iossifov I, Grabill I et al (2011)
A comparative analysis of exome capture.
Genome Biol 12:97
17. Welander J, Andreasson A, Juhlin CC et al
(2014) Rare germline mutations identified
by targeted next-generation sequencing of
susceptibility genes in pheochromocytoma
and paraganglioma. J Clin Endocrinol Metab
99:1352–1360
18. Quail MA, Smith M, Coupland P et al (2012)
A tale of three next generation sequencing
platforms: comparison of Ion Torrent, Pacific
Biosciences and Illumina MiSeq sequencers.
BMC Genomics 13:341
19. Margulies M, Egholm M, Altman WE et al
(2005) Genome sequencing in microfabri-
cated high-density picolitre reactors. Nature
43:376–380
20. Moorthie S, Mattocks CJ, Wright CF (2011)
Review of massively parallel DNA sequencing
technologies. HUGO J 5:1–12
Suja Pillai et al.